Summary
Natac Biotech S.L. is the R&D division of a group of 8 companies (Natac Group S.L.) with headquarters in Spain and international presence in EU, LATAM and the USA. Our group is a leading firm of the natural extracts sector and we have developed and operated the first olive biorefinery at a global level. Thanks to this, we can obtain high added value bioactive ingredients from residues of olive oil production (circular bio-economy) at industrial quantities and very competitive prices.
In our effort to continue innovating and expanding, the AQUOLIVE project is now the most strategic project for us, as a way to become a leading player of the animal nutrition market. The AQUOLIVE project is aimed at offering the aquaculture sector a high-performance feed additive based on our patented formulation of bioactive phytochemicals obtained from olive oil production by-products (production method also patented). This solution will help Fish farmers to increase their productivity and profitability, while reducing the use of hazardous antimicrobial chemicals in intensive aquaculture practices.
Thanks to the clear benefits AQUOLIVE will bring to fish farmers and the industry need for this type of solution, we see in the AQUOLIVE project a clear investment opportunity, in which we seek entering the fast-growing aquaculture feed market. This market was value globally at €156 Billion in 2015 and project to €209 Billion by 2019. More precisely, AQUOLIVE will target the salmon feed market, with a global production of 7 MTon in 2017 and that accounts for a total of 11% share of the total production of aquafeed products globally. In this growing market scenario, our 3-years business plan after this Phase 2 project will mean a 3-years cumulative cash flow of €9.02 Million meaning a 3-years after-tax ROI of 362% for a total investment of €2.49 Million in the Phase 2 project (€1.74 M of EU contribution).
In our effort to continue innovating and expanding, the AQUOLIVE project is now the most strategic project for us, as a way to become a leading player of the animal nutrition market. The AQUOLIVE project is aimed at offering the aquaculture sector a high-performance feed additive based on our patented formulation of bioactive phytochemicals obtained from olive oil production by-products (production method also patented). This solution will help Fish farmers to increase their productivity and profitability, while reducing the use of hazardous antimicrobial chemicals in intensive aquaculture practices.
Thanks to the clear benefits AQUOLIVE will bring to fish farmers and the industry need for this type of solution, we see in the AQUOLIVE project a clear investment opportunity, in which we seek entering the fast-growing aquaculture feed market. This market was value globally at €156 Billion in 2015 and project to €209 Billion by 2019. More precisely, AQUOLIVE will target the salmon feed market, with a global production of 7 MTon in 2017 and that accounts for a total of 11% share of the total production of aquafeed products globally. In this growing market scenario, our 3-years business plan after this Phase 2 project will mean a 3-years cumulative cash flow of €9.02 Million meaning a 3-years after-tax ROI of 362% for a total investment of €2.49 Million in the Phase 2 project (€1.74 M of EU contribution).
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/830202 |
| Start date: | 01-03-2019 |
| End date: | 31-08-2021 |
| Total budget - Public funding: | 2 492 182,25 Euro - 1 744 527,00 Euro |
Cordis data
Original description
Natac Biotech S.L. is the R&D division of a group of 8 companies (Natac Group S.L.) with headquarters in Spain and international presence in EU, LATAM and the USA. Our group is a leading firm of the natural extracts sector and we have developed and operated the first olive biorefinery at a global level. Thanks to this, we can obtain high added value bioactive ingredients from residues of olive oil production (circular bio-economy) at industrial quantities and very competitive prices.In our effort to continue innovating and expanding, the AQUOLIVE project is now the most strategic project for us, as a way to become a leading player of the animal nutrition market. The AQUOLIVE project is aimed at offering the aquaculture sector a high-performance feed additive based on our patented formulation of bioactive phytochemicals obtained from olive oil production by-products (production method also patented). This solution will help Fish farmers to increase their productivity and profitability, while reducing the use of hazardous antimicrobial chemicals in intensive aquaculture practices.
Thanks to the clear benefits AQUOLIVE will bring to fish farmers and the industry need for this type of solution, we see in the AQUOLIVE project a clear investment opportunity, in which we seek entering the fast-growing aquaculture feed market. This market was value globally at €156 Billion in 2015 and project to €209 Billion by 2019. More precisely, AQUOLIVE will target the salmon feed market, with a global production of 7 MTon in 2017 and that accounts for a total of 11% share of the total production of aquafeed products globally. In this growing market scenario, our 3-years business plan after this Phase 2 project will mean a 3-years cumulative cash flow of €9.02 Million meaning a 3-years after-tax ROI of 362% for a total investment of €2.49 Million in the Phase 2 project (€1.74 M of EU contribution).
Status
CLOSEDCall topic
EIC-SMEInst-2018-2020Update Date
27-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Search
